Japan

According to GlobalData’s Epidemiology and Market Size Database, the value of the plaque psoriasis market in Japan is estimated to…

As per the agreement, Novumcella will initially provide regulatory support services to Stempeutics for getting approval from…

The data reported to Japan’s health ministry by hospitals treating people showing mild or no symptoms raises doubts about whether…

According to GlobalData’s report, ‘Rheumatoid Arthritis: Global Drug Forecast and Market Analysis to 2027, Japan contributed…

The certificate is valid till September 2024 Lupin announced the receipt of GMP (Good Manufacturing Practice) Certificate from…

The Japanese government made reforms in 2018 that change how its national health system pays for new and innovative drugs

Japan is a key market with approximately 430,000 people currently suffering from psoriasis and psoriatic arthritis

Acquires 14 prescription brands Sun Pharma has acquired 14 established prescription brands from Novartis in Japan. According to…

Kyowa Pharmaceutical Industry Co will set up the plant at Tottori, as part of expansion plans in the country

Daiichi Sankyo said it would disclose the financial details related to the Sun Pharma stake sale when it announces results for the…